Posted by Michael Wonder on 06 Dec 2016
Novo Nordisk becomes second major drug maker to limit price hikes
5 December 2016 - Yet another major drug maker is pledging to limit price hikes.
In an open letter discussing the cost of medicines, Novo Nordisk President Jakob Riis promised not to raise the list price of any medicine by more than single-digit percentages annually. “This is one action we are taking immediately,” he wrote on the company web site. The message was actually posted last Wednesday, but not immediately publicised by the company, which specialises in diabetes drugs.
“We hear from more and more people living with diabetes about the challenges they face affording healthcare, including the medicines we make. We take this issue seriously and have been thinking about what we can do to better support patients,” Riis explained. “This has become a responsibility that needs to be shared among all those involved in health care and we’re going to do our part.”
